|
|
市场分析报告
|
EPIX Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... trials in Alzheimers disease. PRX-08066 for Pulmonary Hypertension: PRX-08066 is a selective, small- ... 5-HT2B. The company is developing PRX-08066 for the treatment of pulmonary ... plc and Pfizer, Inc. PRX-08066: If approved, PRX-08066, the drug candidate the ...
Clinical Data, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Pharmaceuticals, Inc. (Epix) related to the PRX-08066 drug program, which is a selective 5-HT2B ...
|
|
|
|